Skip to main content
. Author manuscript; available in PMC: 2014 Apr 10.
Published in final edited form as: J Nucl Med. 2012 Aug 23;53(10):1592–1600. doi: 10.2967/jnumed.111.102293

FIGURE 4.

FIGURE 4

Biodistribution of 89Zr-oxalate in MKN-45 xenografts after 1, 3, and 5 d and for comparison 89Zr-df-Onartuzumab tumor and femur uptakes (*, %ID/g). Each bar represents %ID/g ± SD ([89Zr]-oxalate, n=3; 89Zr-df-Onartuzumab, n= 3).